China online pharmaceutical trading site raises $16m
Yaoshibang, a Chinese B2B pharmaceutical trading platform, has raised a RMB110 million ($16 million) Series B round co-led by Shenzhen-based Green Pine Capital Partners and Fosun Group.
Existing investors Co-Power Capital and Ivy Capital also participated in the round. Operated by Guangzhou Speedroad Medical Information, Yaoshibang was launched in 2015 by a former executive at Chinese...
More on Greater China
Latest News
India's Innoven fractionalises venture debt fund
India’s Innoven Capital, a joint venture between UOB and Temasek Holdings-owned Seviora Holdings, has fractionalised a USD 50m venture debt fund using blockchain and smart contracts.
Australian needle-free vaccine start-up raises $23m
OneVentures and UniQuest have led a AUD 34m (USD 23m) funding round for Vaxxas, an Australia-based biotechnology company running clinical programmes that include a needle-free COVID-19 vaccine candidate.
Temasek, A91, Kae back $135m round for India's HealthKart
Temasek Holdings, A91 Partners, and Kae Capital have invested USD 135m in Indian omnichannel wellness products retailer HealthKart.
Northleaf launches Tokyo office, targets Asian LPs
Northleaf Capital Partners, a Canada-based asset manager that invests in private equity, private credit, and infrastructure, has opened a Tokyo office to spearhead fundraising activity in Asia and is considering the addition of a Korea presence.